Buy - Price 29.87 on Aug. 11
by Maxim Group

This [China-based developer, manufacturer and exporter of medical devices for patient-monitoring, diagnostics and ultrasound-imaging systems] reported strong 2Q09 results, with net revenue of $160 million -- beating our estimate of $143 million and the consensus of $152 million. Management comment[ed] that 2009 net revenue should grow at a rate of at least 10% year/over/year...We are encouraged about the outlook for Mindray...On a quarter/over/quarter basis, revenue from China and international revenue were up 22% and 17%, respectively. We view the expansion of Chinese revenue as in line with expectations, but are encouraged by the expansion of international sales, given the globally challenging hospital-spending environment. Revenues from all three product groups expanded q/o/q. Market cap: $2.4 billion.

china play..these guys are constantly bringing new products to market and are poised to reap profits both at home and abroad.

don't have one

11.6

growth

9:30

good financials. Great growth

GROWTH

Chinese medical company. Does not have any subprime exposure :)

Mindray Medical Intl ( MR ) makes and sells medical devices. The stock has a P/E of 68.03 and a PEG of 1.56.

Frankly, I love this stock, but not at its current price of $44. There are other cheap chinese stocks that I will prefer.

Chinese ADRs

.76

may bounce back